Universe Pharmaceuticals (UPC) Enterprise Value (2020 - 2025)
Historic Enterprise Value for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to -$33.6 billion.
- Universe Pharmaceuticals' Enterprise Value fell 40414.86% to -$33.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$33.6 billion, marking a year-over-year decrease of 40414.86%. This contributed to the annual value of -$29.5 billion for FY2025, which is 34270.09% down from last year.
- Universe Pharmaceuticals' Enterprise Value amounted to -$33.6 billion in Q3 2025, which was down 40414.86% from -$6.7 billion recorded in Q3 2024.
- Universe Pharmaceuticals' 5-year Enterprise Value high stood at -$1.4 million for Q3 2023, and its period low was -$33.6 billion during Q3 2025.
- In the last 5 years, Universe Pharmaceuticals' Enterprise Value had a median value of -$27.4 million in 2022 and averaged -$5.8 billion.
- In the last 5 years, Universe Pharmaceuticals' Enterprise Value soared by 9997.6% in 2023 and then tumbled by 48528005.3% in 2024.
- Quarter analysis of 5 years shows Universe Pharmaceuticals' Enterprise Value stood at -$21.8 million in 2021, then crashed by 26155.92% to -$5.7 billion in 2022, then surged by 99.98% to -$1.4 million in 2023, then tumbled by 485280.05% to -$6.7 billion in 2024, then plummeted by 404.15% to -$33.6 billion in 2025.
- Its last three reported values are -$33.6 billion in Q3 2025, -$6.7 billion for Q3 2024, and -$7.8 million during Q1 2024.